HMHiroshi Mikamo

Hiroshi Mikamo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroshi Mikamo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum IgG4-negative IgG4-related disease with a cardiac mass: A case report

    by Kensuke Namba, Daiki Sakai, Hiroshi Mikamo, Yuta Sugizaki, Yoshiya Sugiura, Nobuyuki Hiruta, Yasuo Matsuzawa, Kaichi Kaneko

    Rationale: Although IgG4-related disease (IgG4-RD) can affect various organs, its association with a cardiac mass is exceptionally rare. Here, we report a case of a woman with IgG4-RD and a cardiac mass and discuss 10 similar cases reported previously. Patient concerns: A 65-year-old woman was referred to our hospital for chest discomfort and back pain. Diagnoses: In accordance with the 2019 ACR/EULAR diagnostic criteria for IgG4-RD, she was diagnosed with IgG4-RD based on dense lymphocytic infiltration on histopathology, IgG/IgG4-positive cell ratio 10/hpf IgG4-positive cells on immunostaining, and paraspinal zone soft tissue lesions in the chest. Interventions: An external pacemaker was implanted for the complete atrioventricular block on the electrocardiogram. After the diagnosis of IgG4-RD, she was treated with glucocorticoids and rituximab. Outcomes: She remains under observation without disease recurrence. Lessons: IgG4-RD are usually treated with glucocorticoids; however, in cases of a cardiac mass, life-threatening complications may occur and surgery is often needed. Combination therapy with glucocorticoids and rituximab may be effective even in patients with IgG4-RD and cardiac mass, which may avoid the need of invasive treatments, such as surgery.